5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neuropharmacology

• Publication date

  2004-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.NEUROPHARM.2004.03.012PMID 15223298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.

  2003cited by this paper
• Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790

  2003cited by this paper
• Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats.

  2002cited by this paper
• Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat

  2002cited by this paper
• Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist.

  2002cited by this paper
• Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease

  2001cited by this paper
• The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus.

  2001cited by this paper
• 5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides.

  2001cited by this paper
• Effects of the 5-HT(6) receptor antagonist Ro 04-6790 on learning consolidation.

  2001cited by this paper
• 5-HT6 receptor antagonists enhance retention of a water maze task in the rat

  2001cited by this paper
• The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus

  2001cited by this paper
• A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

  2001cited by this paper
• NMDA antagonists produce site-selective impairment of accuracy in a delayed nonmatch-to-sample task in rats.

  2001cited by this paper
• Impaired Recognition Memory in Rats after Damage to the Hippocampus

  2000cited by this paper
• Characterization of SB‐271046: A potent, selective and orally active 5‐HT6 receptor antagonist

  2000cited by this paper
• In vivo effects of the 5‐HT6 antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartate

  2000cited by this paper
• Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease.

  1999cited by this paper
• Investigation of stretching behaviour induced by the selective 5‐HT6 receptor antagonist, Ro 04–6790, in rats

  1999cited by this paper
• Delay‐dependent impairment of a matching‐to‐place task with chronic and intrahippocampal infusion of the NMDA‐antagonist D‐AP5

  1999cited by this paper
• Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus.

  1999cited by this paper
• 5-HT6 RECEPTORS: FUNCTIONAL CORRELATES AND POTENTIAL THERAPEUTIC INDICATIONS

  1999cited by this paper
• 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.

  1999cited by this paper
• Involvement of 5‐HT6 receptors in nigro‐striatal function in rodents

  1998cited by this paper
• Effects of lesions of the Substantia Innominata/Ventral Pallidum, globus pallidus and medial septum on rat's performance in object-recognition and radial-maze tasks: physostigmine and amphetamine treatments.

  1998cited by this paper
• Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT6 receptors

  1998cited by this paper
• Effects of intraseptal infusions of N-methyl-D-aspartate receptor ligands on memory in an object recognition task in rats.

  1998cited by this paper
• The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat.

  1997cited by this paper
• Functional Mapping of Dorsal and Median Raphe 5‐Hydroxytryptamine Pathways in Forebrain of the Rat Using Microdialysis

  1997cited by this paper
• Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat.

  1997cited by this paper
• Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix

  1997cited by this paper
• Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system.

  1997cited by this paper
• Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures.

  1997cited by this paper
• Colocalization of serotonin receptor subtypes 5‐HT2A, 5‐HT2C, and 5‐HT6 with neuropeptides in rat striatum

  1996cited by this paper
• Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

  1996cited by this paper
• Quantitative RT‐PCR distribution of serotonin 5‐HT6 receptor mRNA in the central nervous system of control or 5,7‐dihydroxytryptamine‐treated rats

  1996cited by this paper
• Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat.

  1996cited by this paper
• Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry.

  1995cited by this paper
• Lesions of rat perirhinal cortex exacerbate the memory deficit observed following damage to the fimbria-fornix.

  1995cited by this paper
• Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides.

  1995cited by this paper
• Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

  1993cited by this paper
• Impaired object recognition memory in rats following ischemia-induced damage to the hippocampus.

  1993cited by this paper
• A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

  1993cited by this paper
• Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.

  1993cited by this paper
• Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests

  1992cited by this paper
• NMDA receptor channel antagonism by dizocilpine (MK-801) impairs performance of rats in aversively motivated complex maze tasks.

  1991cited by this paper
• Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.

  1989cited by this paper
• A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam.

  1989cited by this paper
• Excitatory amino acids and Alzheimer's disease.

  1989cited by this paper
• A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

  1988cited by this paper
• Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors.

  1984cited by this paper
• Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus.

  1983cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper

• Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges

  2025cites this paper
• Differential role of NMDA receptors in hippocampal‐dependent spatial memory and plasticity in juvenile male and female rats

  2024cites this paper
• 5-HT6 Receptors Sex-Dependently Modulate Hippocampal Synaptic Activity through GABA Inhibition

  2023cites this paper
• spatial learning performance and altered

  2023cites this paper
• Synthesis and structure activity relationship studies of 2‐amino‐4‐arylysulfonyl‐5,6,7,8‐tetrahydroquinazolines as 5‐HT 6 receptor antagonists

  2023cites this paper
• Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease.

  2023cites this paper
• The role of serotonin in declarative memory: a systematic review of animal and human research.

  2022cites this paper
• Combination of MAP6 deficit, maternal separation and MK801 in female mice: A 3-hit animal model of neurodevelopmental disorder with cognitive deficits.

  2021cites this paper
• Fyn kinase inhibition using AZD0530 improves recognition memory and reduces depressive-like behaviour in an experimental model of Parkinson’s disease

  2021influential citation
• Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

  2020cites this paper
• Role of Neurochemicals in Schizophrenia

  2020cites this paper
• Functional pharmacogenetics of serotonin receptors in psychiatric drug action

  2020cites this paper
• Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management

  2020cites this paper
• Calbindin Deficits May Underlie Dissociable Effects of 5-HT6 and mGlu7 Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia

  2020cites this paper
• Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.

  2020cites this paper
• The blockade of the serotoninergic receptors 5-HT5A, 5-HT6 and 5-HT7 in the basolateral amygdala, but not in the hippocampus facilitate the extinction of fear memory.

  2019cites this paper
• 5-HT6 receptor agonist and antagonist improve memory impairments and hippocampal BDNF signaling alterations induced by MK-801.

  2019cites this paper
• Serotonin Receptors as the Therapeutic Target for Central Nervous System Disorders

  2019cites this paper
• Impact of early exposure to a cafeteria diet on prefrontal cortex monoamines and novel object recognition in adolescent rats

  2019cites this paper
• Monoamines and their derivatives on GPCRs: potential therapy for Alzheimer's Disease.

  2019cites this paper
• The NMDA receptor antagonist MK-801 fails to impair long-term recognition memory in mice when the state-dependency of memory is controlled

  2019cites this paper
• SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization

  2019cites this paper
• Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice

  2018cites this paper
• Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: Implications for mechanisms of post-traumatic headache

  2018cites this paper
• The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats

  2018cites this paper
• 5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats

  2018cites this paper
• A continual trials approach to recognition memory in mice

  2018cites this paper
• Novel Object Recognition Test in Rodents:: Which Roles for Serotonin Receptors?

  2018cites this paper
• Object Novelty Memory Tests

  2018cites this paper
• 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer’s disease

  2018cites this paper
• Anxiety‐ and activity‐related effects of paracetamol on healthy and neuropathic rats

  2017cites this paper
• Time‐dependent impact of glutamatergic modulators on the promnesiant effect of 5‐HT6R blockade on mice recognition memory

  2017cites this paper
• Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease.

  2017cites this paper
• Potential drug targets and treatment of schizophrenia

  2017cites this paper
• Role of the anterior cingulate cortex in the retrieval of novel object recognition memory after a long delay

  2017cites this paper
• A new serotonin 5-HT6 receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding

  2017cites this paper
• Neuropathological Background of MK-801 for Inducing Murine Model of Schizophrenia

  2017cites this paper
• Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia

  2016cites this paper
• Impaired recognition memory and cognitive flexibility in the ratL5–L6 spinal nerve ligation model of neuropathic pain

  2016cites this paper
• Impaired cued and spatial learning performance and altered cannabinoid CB₁ receptor functionality in the substantia nigra in a rat model of diabetic neuropathy.

  2016cites this paper
• 1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.

  2016cites this paper
• Striatal 5-HT6 receptors: Roles in cocaine reinforcement and neuronal primary cilia

  2016cites this paper
• Pro‐cognitive action of CART is mediated via ERK in the hippocampus

  2016cites this paper
• Psycho-Oncologic Effects of Serotonin and Melatonin

  2016cites this paper
• Activation and blockade of serotonin6 receptors in the dorsal hippocampus enhance T maze and hole-board performance in a unilateral 6-hydroxydopamine rat model of Parkinson's disease.

  2016cites this paper
• Thur, Karen E. and Nelson, Andrew J.D. and Cassaday, Helen J. (2014) Ro 04-6790-induced cognitive enhancement: No effect in trace conditioning and novel object recognition procedures in adult male Wistar rats

  2016influential citation
• Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats

  2016cites this paper
• Design, Synthesis and Evaluation of Substituted 3-(1, 4-Diazepanyl)-Methyl-Phenyl-Sulphonamides as Potent 5-HT6 Antagonists in Cognitive Disorders

  2016cites this paper
• The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.

  2016cites this paper
• 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia.

  2015cites this paper
• Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia

  2015cites this paper
• Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.

  2015cites this paper
• The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophrenia.

  2015cites this paper
• New insight into the therapeutic role of the serotonergic system in Parkinson's disease.

  2015cites this paper
• Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine.

  2015cites this paper
• 6-Sulfonylbenzothiazolones as potential scaffolds for the design of 5-HT6 ligands.

  2015cites this paper
• Dopamine D1 receptor stimulation modulates the formation and retrieval of novel object recognition memory: Role of the prelimbic cortex

  2015cites this paper
• Declarative memory.

  2015cites this paper
• Cognitive Enhancement

  2015cites this paper
• The impact of cafeteria feeding during lactation in the rat on novel object 1 discrimination in the offspring 2 3

  2015cites this paper
• Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.

  2015cites this paper
• Effects of Asiatic Acid on Spatial Working Memory and Cell Proliferation in the Adult Rat Hippocampus

  2015cites this paper
• Interacción de los receptores NMDA - 5-HT6 en la investigación preclínica de las alteraciones cognitivas relacionadas con la esquizofrenia

  2015cites this paper
• Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

  2014cites this paper
• Sulfonyl-containing modulators of serotonin receptors and their pharmacophore models

  2014cites this paper
• Impact of cafeteria feeding during lactation in the rat on novel object discrimination in the offspring

  2014cites this paper
• The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia.

  2014cites this paper
• Serotonin 5-HT3 Receptor-Mediated Vomiting Occurs via the Activation of Ca2+/CaMKII-Dependent ERK1/2 Signaling in the Least Shrew (Cryptotis parva)

  2014cites this paper
• The role of serotonin in memory: interactions with neurotransmitters and downstream signaling

  2014cites this paper
• Role of glutamate and advantages of combining memantine with a 5HT_6 ligand in a model of depression

  2014cites this paper
• The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia

  2014cites this paper
• Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative

  2014cites this paper
• Computational approaches to the design of novel 5-HT6 R ligands

  2014cites this paper
• Alzheimer’s Disease and Animal Models in Retrospect

  2014cites this paper
• Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of ‘schizophrenia-like’ behaviour in the rat

  2014cites this paper
• Evaluation of novel dual-hit models of 'schizophrenia-like' symptoms in the rat

  2014influential citation
• 5-HT6 receptor antagonists as treatment for age-related cognitive decline

  2014cites this paper
• Ro 04-6790-induced cognitive enhancement: No effect in trace conditioning and novel object recognition procedures in adult male Wistar rats

  2014influential citation
• Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat.

  2013cites this paper
• The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice

  2013cites this paper
• Kami-ondam-tang, a traditional herbal prescription, attenuates the prepulse inhibition deficits and cognitive impairments induced by MK-801 in mice.

  2013cites this paper
• Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice

  2013cites this paper
• Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions.

  2013cites this paper
• Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.

  2013cites this paper
• Synthesis and the 5-HT6 receptor antagonistic effect of 3-arylsulfonylamino-5,6-dihydro-6-substituted pyrazolo[3,4]pyridinones for neuropathic pain treatment.

  2013cites this paper
• Different MK-801 administration schedules induce mild to severe learning impairments in an operant conditioning task: role of buspirone and risperidone in ameliorating these cognitive deficits.

  2013cites this paper
• Serotonin 6 receptor gene and schizophrenia: case‐control study and meta‐analysis

  2012cites this paper
• The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats

  2012influential citation
• 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice

  2012cites this paper
• Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457.

  2012influential citation
• 5‐HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms

  2012cites this paper
• Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.

  2012cites this paper
• Behavioral animal models to assess pro-cognitive treatments for schizophrenia.

  2012cites this paper
• Psychopharmacological treatment of schizophrenia: what do we have, and what could we get?

  2012cites this paper
• Object recognition testing: statistical considerations.

  2012cites this paper
• What is the prognosis for new centrally-acting anti-obesity drugs?

  2012cites this paper
• Behavioral and biochemical characterization of rats treated chronically with thioacetamide: proposal of an animal model for hepatic encephalopathy associated with cirrhosis.

  2012cites this paper
• Mouse pharmacological models of cognitive disruption relevant to schizophrenia.

  2012cites this paper
• 5‐HT2C and 5‐HT6 Receptor Targeted Emerging Approaches in Schizophrenia

  2012cites this paper
• The Effect of Pain on Cognitive Function: Preclinical and Clinical Investigations

  2012cites this paper